AI assistant
Sending…
LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2012
Oct 9, 2012
33431_dirs_2012-10-09_5b549f89-8eb5-4cab-b4a6-f5b87ff821e7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2012-10-08
Reporting Person: STEELE GARY T (Director, CEO and President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-10-08 | Common Stock | M | 16045 | $2.82 | Acquired | 124525 | Indirect |
| 2012-10-08 | Common Stock | M | 16045 | $11 | Disposed | 108480 | Indirect |
| 2012-10-08 | Common Stock | M | 23955 | $10.99 | Disposed | 84525 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-10-08 | Nonqualified Stock Option | $2.82 | M | 16045 | Disposed | 2013-02-20 | Common Stock (16045) | Indirect |
More from LIFECORE BIOMEDICAL, INC. \DE\
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Jan 16
Investor Presentation
2025
Nov 17
Interim / Quarterly Report
2025
Nov 6
Earnings Release
2025
Nov 6
Declaration of Voting Results & Voting Rights Announcements
2025
Oct 31
Major Shareholding Notification
2025
Oct 17
Regulatory Filings
2025
Oct 1